Instead of waiting for allergy patients to have symptoms on study days, Dr. Abelson’s team created a model to induce the allergic reaction in a controlled way. This 'Conjunctival Allergy Challenge' allowed for precise, predictable testing of new drugs, dramatically speeding up development.

The 1945 death of President Roosevelt from a stroke highlighted medicine's profound ignorance about cardiovascular disease. This high-profile event spurred the government to create the National Heart Institute and fund the groundbreaking Framingham Heart Study.

The key insight behind Operation Warp Speed's success, according to Ken Griffin, was solving an incentive problem. The US government funded vaccine manufacturing *before* FDA approval, assuming the financial risk from pharmaceutical companies who wouldn't otherwise spend billions on a product that might fail.

The scientific response to AIDS was marked by hyper-competitiveness and siloed "camps," a stark contrast to the collaborative spirit of WWII drug development. A proposal for a "Manhattan Project for AIDS" to share information and reagents was rejected, revealing a cultural shift away from unified crisis response.

Even in a total war, victory depends on having the flexibility to dedicate a small portion of resources—perhaps 10-20%—to high-risk, long-term innovations like the jet engine. Bureaucratic pressure to focus only on immediate needs can stifle the very breakthroughs that ultimately win the war.

Dr. Plotkin was assigned to an anthrax lab against his wishes. When a sudden outbreak occurred, his successful investigation gave him the credibility to persuade his director to let him work on his true passion, polio vaccines. This shows how embracing unexpected challenges can unlock desired opportunities.

Agencies like BARDA are funding drugs that treat severe symptoms common to various pathogens, such as acute respiratory distress syndrome (ARDS). This strategy aims to have pre-approved, pathogen-agnostic treatments available immediately during a new pandemic to reduce mortality while vaccines are developed.

Diseases like Ebola and malaria, which primarily affect poor countries, lack market incentives for vaccine R&D. The Ebola vaccine only progressed because it was briefly on a U.S. bioterrorism list created after 9/11, highlighting how market failures require creative, sometimes accidental, incentives to overcome.

While penicillin was a "one-off" discovery, Selman Waksman developed a systematic method to find new drugs. Reasoning that soil microbes consumed other microbes, he created a process to screen for these agents, coining the term "antibiotic" and discovering the tuberculosis drug streptomycin.